Mathes Company, Inc. Merck & Co., Inc. Transaction History

Mathes Company, Inc.

$275 Million
Q2 2024

A detailed history of Mathes Company, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mathes Company, Inc. holds 5,550 shares of MRK stock, worth $630,258. This represents 0.25% of its overall portfolio holdings.

Number of Shares

5,550

Previous 6,550 15.27%

Holding current value

$630,258

Previous $864,000 20.49%

% of portfolio

0.25%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $123,800 - $132,960	-1,000 Reduced 15.27%	5,550 $687,000
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $167,693 - $182,778	-1,544 Reduced 19.08%	6,550 $756,000
Q2 2022 Aug 01, 2022	SELL	$83.49 - $94.64 $10,269 - $11,640	-123 Reduced 1.5%	8,094 $738,000
Q4 2021 Feb 04, 2022	SELL	$72.28 - $90.54 $89,482 - $112,088	-1,238 Reduced 13.09%	8,217 $630,000
Q2 2021 Jul 20, 2021	SELL	$70.31 - $77.77 $63,279 - $69,993	-900 Reduced 8.69%	9,455 $735,000
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $10,765 - $11,947	-150 Reduced 1.43%	10,355 $847,000
Q2 2020 Jul 27, 2020	SELL	$70.42 - $80.13 $70,420 - $80,130	-1,000 Reduced 8.69%	10,505 $812,000
Q1 2020 Apr 21, 2020	SELL	$63.36 - $87.82 $3,801 - $5,269	-60 Reduced 0.52%	11,505 $885,000
Q4 2019 Jan 30, 2020	SELL	$77.58 - $87.54 $86,656 - $97,782	-1,117 Reduced 8.81%	11,565 $1.05 Million
Q2 2019 Jul 29, 2019	SELL	$69.84 - $81.59 $225,932 - $263,943	-3,235 Reduced 20.32%	12,682 $1.06 Million
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $420,959 - $480,128	-6,050 Reduced 27.54%	15,917 $1.32 Million
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $19,326 - $22,726	-335 Reduced 1.5%	21,967 $1.56 Million
Q2 2018 Jul 27, 2018	BUY	$50.83 - $59.72 $10,166 - $11,944	200 Added 0.9%	22,302 $1.35 Million
Q1 2018 Apr 27, 2018	BUY	$50.96 - $59.23 $169,696 - $197,235	3,330 Added 17.74%	22,102 $1.2 Million
Q4 2017 Jan 19, 2018	SELL	$51.62 - $61.64 $98,078 - $117,116	-1,900 Reduced 9.19%	18,772 $1.06 Million
Q3 2017 Oct 20, 2017	BUY	$58.67 - $63.13 $1.21 Million - $1.31 Million	20,672	20,672 $1.32 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Account

Mathes Company, Inc. Merck & Co., Inc. Transaction History